Nicotinamide adenine dinucleotide rejuvenates septic bone marrow mesenchymal stem cells

Sepsis accelerates the aging of BMSCs, as evidenced by a decline in self-renewal and osteogenic capabilities, as well as weakened hematopoietic support functions. These deficiencies can be effectively reversed <i>via</i> the NAD/SIRT3/superoxide dismutase pathway.

Authors

Institutions

Publication Details

Journal
World Journal of Stem Cells
Published
2025-02-24
DOI
https://doi.org/10.4252/wjsc.v17.i2.96893
Citations
3
Primary Topic
PARP inhibition in cancer therapy
Type
article
Field-Weighted Citation Impact
3.14
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Nicotinamide adenine dinucleotide rejuvenates septic bone marrow mesenchymal stem cells

Zhigang Zhou, Tong Yin, Jinyan Zhao, Kun Zhou et al.
3 citations
World Journal of Stem Cells
PARP inhibition in cancer therapy
3.14
article

Nicotinamide adenine dinucleotide rejuvenates septic bone marrow mesenchymal stem cells

Zhigang Zhou, Tong Yin, Jinyan Zhao, Kun Zhou, Min Zhao, Xin Xia, Brian Tian, Lin-Ying An
article en
3 citations

Abstract

Sepsis accelerates the aging of BMSCs, as evidenced by a decline in self-renewal and osteogenic capabilities, as well as weakened hematopoietic support functions. These deficiencies can be effectively reversed <i>via</i> the NAD/SIRT3/superoxide dismutase pathway.

World Journal of Stem CellsVol. 17(2)
Shanghai Jiao Tong University (CN), Shanghai First People's Hospital (CN)
Openalex Percentile: Top 9%
PARP inhibition in cancer therapy
3.14
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.